Skip to content
HowShorted

Cidara Therapeutics, Inc. short interest in 2021

In 2021, Cidara Therapeutics, Inc.'s disclosed short interest ran from 3.27% of shares outstanding on 15 Jan 2021 to 0.90% on 31 Dec 2021, a change of -2.37 percentage points. The year's high was 4.11% on 15 Apr 2021 and its low 0.70% on 15 Nov 2021, averaging 2.30% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 6.82 days on 15 Jun 2021. Full history: Cidara Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025

Aggregate net short position time series for Cidara Therapeutics, Inc. in 2021

2021 in figures

Start of year
3.27% (15 Jan 2021)
End of year
0.90% (31 Dec 2021)
Change
-2.37 pp
High
4.11% (15 Apr 2021)
Low
0.70% (15 Nov 2021)
Average
2.30%
Highest days to cover
6.82 (15 Jun 2021)
SEC filings marked
8

Every report in 2021

Cidara Therapeutics, Inc. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 20213.27%3.05
29 Jan 20213.22%4.02
12 Feb 20213.62%1.62
26 Feb 20213.64%1.0010-K filed, results (8-K)
15 Mar 20213.47%2.07
31 Mar 20213.69%4.44
15 Apr 20214.11%1.38
30 Apr 20213.97%4.51
14 May 20213.55%3.8810-Q filed, results (8-K)
28 May 20213.40%6.77
15 Jun 20213.33%6.82
30 Jun 20211.98%1.19
15 Jul 20211.69%1.93
30 Jul 20211.43%2.66
13 Aug 20211.54%3.2610-Q filed, results (8-K)
31 Aug 20211.40%1.50
15 Sep 20211.32%3.02
30 Sep 20211.37%2.17
15 Oct 20211.17%1.00
29 Oct 20210.80%1.34
15 Nov 20210.70%1.0010-Q filed, results (8-K)
30 Nov 20210.93%1.00
15 Dec 20210.76%1.00
31 Dec 20210.90%1.00

See also: Cidara Therapeutics, Inc.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.